A PK2/Bv8/PROK2 Antagonist Suppresses Tumorigenic Processes by Inhibiting Angiogenesis in Glioma and Blocking Myeloid Cell Infiltration in Pancreatic Cancer

• Valerie F. Curtis,

  Affiliation Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, United States of America

  ⨯
• Hui Wang,

  Affiliation Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, United States of America

  ⨯
• Pengyuan Yang,

  Affiliation Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, United States of America

  ⨯
• Roger E. McLendon,

  Affiliation Department of Pathology, Duke University, Durham, North Carolina, United States of America

  ⨯
• Xiaohan Li,

  Affiliation Department of Pharmacology, University of California Irvine, Irvine, California, United States of America

  ⨯
• Qun-Yong Zhou,

  Affiliation Department of Pharmacology, University of California Irvine, Irvine, California, United States of America

  ⨯
• Xiao-Fan Wang

  * E-mail: xiao.fan.wang@duke.edu

  Affiliation Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, United States of America

  ⨯